Seres Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:MCRB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -38.88 M26.91 M-13.29 M2.21 M-14.71 M 1.12 M Cash from investing activities -90 K-34 K-181 K-8 000181 K -42 K Cash from financing activities 1.74 M1.18 M061 K12.66 M 13.9 M Free cash flow -38.97 M26.88 M-13.47 M2.2 M-14.74 M 865 K

News

Seres Therapeutics schedules 2026 annual meeting for June 9

Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome Therapeutics Platform Prepared Remarks Transcript

Seres stock falls after pausing Phase 2 study and cutting workforce by 30%

Seres Therapeutics: Strong SER-155 Data, But Dilution Risk Now Warrants A 'Hold'

Seres Therapeutics publishes new insights on VOWST mechanism

3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround

Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director

Seres to present new data on SER-155 bloodstream infection study

Seres Therapeutics announces workforce reduction to extend cash runway

Factbox-More companies adopt co-CEO structure

Canaccord Genuity raises Seres Therapeutics stock price target to $22 on FDA hopes

Seres Therapeutics advances SER-155 protocol after FDA feedback